Management of early rectal carcinoma Joint Hospital Surgical Grand Round Jeren Lim United Christian Hospital.

Slides:



Advertisements
Similar presentations
Neoadjuvant therapy for Rectal cancer
Advertisements

Taunton SpR Training Day 7th December 2012 Early rectal cancer
Oncologic Results of Laparoscopic Versus Conventional Open Surgery for Stage II or III Left-Sided Colon Cancers A Randomized Controlled Trial A randomized.
North Tees University Hospital Audit of T1 Rectal Cancers September 2013 – August 2014 Nicola Maguire Teaching fellow General Surgery 12/09/2014.
Polyps – Where do they come from and what do you do with them?!
Management of Malignant Polyps Santhat Nivatvongs, MD Colon and Rectal Surgery Mayo Clinic Rochester Minnesota U.S.A.
Endoscopic Ultrasound in Rectal Cancer Natasha Schneider November 15, 2010.
Multimodality Therapy of Rectal Cancer Robert D. Madoff, MD University of Minnesota.
DEBATE: What is the Optimal Sequence of Therapies for Stage II-III Adenocarcinoma of the Proximal Stomach? Michael A. Choti, MD Department of Surgery UT.
Rectal Cancer: A Complete Clinical Response…Now what?
Role of colonoscopy in the treatment of malignant polyps Pathology of malignant colorectal polyps Assessing the risk of residual disease post-polypectomy.
JHSGR Neoadjuvant Therapy For Rectal Cancer Dr Chris TL Cheng Princess Margaret Hospital.
Management of colorectal cancer with liver metastasis Dr. Vivian Lee Department of Surgery, UCH.
Joint Hospital Surgical Grand Round KL FOK NDH/AHNH Department of Surgery.
ANDREW NG PRINCE OF WALES HOSPITAL Role of primary chemoradiation in esophageal carcinoma.
62 years old man Main complaint: Back pain at night but not during the day Loss of appettite Weight loss.
Postoperative Radiation for Oral Cavity Squamous Cell Carcinoma: The EP.
Management of Colorectal Liver Metastasis
Joint Hospital Surgical Grand Round 19 June 2004.
Management of differentiated thyroid cancer Dr. Leung Tak Lun Canice North District Hospital.
Colorectal cancer Khayal AlKhayal MD,FRCSC
Treatment of Early Malignant Rectal Polyp
A REVISIT TO MANAGEMENT OF GASTROINTESTINAL STROMAL TUMOUR (GIST) Joint Hospital Surgical Grand Round 17 Jan 2015 Grace Liu Pamela Youde Nethersole Eastern.
Management of Locally Advanced Rectal Cancer Joint Hospital Surgical Grand Round Pamela Youde Nethersole Eastern Hospital Dr. YH Ling 19 May 2007.
Slawomir Marecik, MD, FACS Advocate Lutheran General Hospital, Park Ridge, IL Clinical Assistant Professor University of Illinois, Chicago, USA.
Dept Surgery, Colorectal unit University Hospital, Uppsala, Sweden
THE SIGNIFICANCE OF HISTOLOGICAL SUBSTAGING IN CURATIVE RESECTED T3 COLORECTAL CANCER Karl Mrak & Jörg Tschmelitsch Department of Surgery, Barmherzige.
Role of EUS in colon lesions Pietro Fusaroli Gastroenterologia Università di Bologna.
A. MONTORI M.D. F.A.C.S. PROFESSOR OF SURGERY UNIVERSITY OF ROME “LA SAPIENZA” President of EAcSS HOW TO AVOID MAJOR SURGERY IN RECTAL CANCER MSO-MTCC.
What is the Preferable Treatment Option for T1/T2 Low Rectal Cancer? Christopher H. Crane, M.D. Program Director, GI Section Department of Radiation Oncology.
Current Role of Partial Cystectomy: Are we scarifying patient ’ s survival Dr Eric Li Department of Surgery Pamela Youde Nethersole hospital.
Colonic stenting for intestinal obstruction due to left colon and rectal cancer Dr Sherman Lam TKOH JHSGR 26 April 2014.
SYNCHRONOUS COLORECTAL AND LIVER RESECTION J Peter A Lodge MD FRCS HPB and Transplant Unit St James’s University Hospital Leeds LS9 7TF 2006 Association.
TME trial TME radiotherapy 5 x 5 Gy TME alone randomisation n = 1861 resectable rectal carcinoma if CRM+: 50 GY.
Transanal Endoscopic Operation Indication – Technique – Results M. Sailer Department of Surgery Bethesda Hospital – Hamburg, Germany.
Delivering clinical research to make patients, and the NHS, better OG neoadjuvant therapy Brachytherapy Stephen Falk dd/mm/yyyy.
Preoperative chemoradiotherapy and postoperative chemotherapy with 5-FU and oxaliplatin versus 5-FU alone in locally advanced rectal cancer: First results.
Pathologist and Prognosis in Colorectal Cancer Surgery. Dr Bryan F Warren Consultant Gastrointestinal Pathologist Oxford M62 Course 2004.
Datum/Vortragsthema Local resection of Rectum tumors Peter M. Markus Elisabeth Hospital Essen Germany.
Accuracy of EUS in diagnosis of rectal cancer KKUH experience
Interesting case. OD yo man with irretrievable rectal TVA on screening colonoscopy, prior transanal excision 8 cm from anal verge Pmhx: hypothyroidism,
J. Lujan, G. Valero, Q. Hernandez, A. Sanchez, M.D. Frutos and P. Parrilla. British Journal of Surgery, September 2009.
Mamoun A. Rahman Surgical SHO Mr Osborne’s team. Introduction Blood transfusion: -Preoperative ( elective) -Intra/postoperative ( urgent) Blood transfusion.
Radical surgery is the preferable treatment option for T1- 2/N0 low rectal cancer Jose G. Guillem, MD, MPH Department of Surgery Memorial Sloan Kettering.
Preliminary Results of the MRC CR07 / NCIC CO16 Randomized Trial Short course pre-op vs selective post-op chemo-RT for rectal cancer Local Recurrence after.
Dr Mark Saunders Christie Hospital and Paterson Institute of Cancer Research “ Rectal cancer radiotherapy – why do we give it and how do we do it?”
Basingstoke Colorectal The Particular Problem of Low Rectal Cancer Brendan Moran Basingstoke 4 th East-West Colorectal Days Hungary 2008.
Role of MRI in Primary Rectal Cancer Staging and Management
Identification of localized rectal cancer (RC) patients (pts) who may NOT require preoperative (preop) chemoradiation (CRT). D. Roda 1, M. Frasson 2, E.
Important questions As good or better ? Cost effective ? Overall, safer? Is it safe as a cancer operation? Can all surgeons do it? Compare to open surgery.
Complete pathologic responses in the primary of rectal or colon cancer treated with FOLFOX without radiation A. Cercek, M. R. Weiser, K. A. Goodman, D.
Addition of Chemotherapy to Preoperative Radiotherapy Improves Outcomes in Rectal Cancer Slideset on: Bosset JF, Calais G, Mineur L, et al. Enhanced tumorocidal.
Neoadjuvant chemotherapy in the treatment of NSCLC Department of Thoracic Oncology, University Hospital Ghent, Belgium Current Opinion in Oncology 2007,
Staging of rectal cancer by EUS: depth of infiltration in T3 cancers is important Christian Jürgensen, MD, Andreas Teubner, MD, Jörg-Olaf Habeck, MD, Friederike.
Henry H L Wu Year 4 Medical Student University of Manchester
Laparoscopic surgery for rectal cancer What is the evidence?
Karcinom rektuma- management
Joint Hospital Surgical Grand Round Dr Stewart Chan Kwong Wah Hospital
Survival analysis of Local excision versus Radical resection for Early-stage Middle and Low Rectal cancer 早期中低位直腸癌的治療: 局部切除與根治性切除之預後分析 賴以立 唐瑞平 陳進勛 游正府.
盧建璋, 陳鴻華, 李克釗, 胡萬祥, 張家駱, 蔡鎧隆, 林岳民, 鄭功全, 吳昆霖
徐慧萍1 羅竹君1,2 郭耀隆1 李國鼎1 國立成功大學醫學院附設醫院外科部1 國立成功大學醫學院臨床醫學研究所2
Dr Jessica Jenkins Consultant Oncologist
Short-term Outcomes of Transanal Total Mesorectal Excision
PRESENTATOR: MD VƯƠNG NHẤT PHƯƠNG. HO CHI MINH CITY ONCOLOGY HOSPITAL
The role of simultaneous resection of synchronous liver metastasis and primary colorectal cancer Samuel Lo Department of Surgery.
The STAR-TREC Trial SIV Presentation
LOCAL EXCISION IN DOWNSTAGED T2T3 LOW RECTAL CANCER 5-year results of the GRECCAR 2 trial E Rullier, V Vendrely, P Rouanet, JJ Tuech, A Valverde, B Lelong,
Presentation transcript:

Management of early rectal carcinoma Joint Hospital Surgical Grand Round Jeren Lim United Christian Hospital

Early rectal carcinoma Adenocarcinoma invaded into, but not beyond the submucosa T1N0M0 tumour 3 – 8.6% of all resected rectal carcinomas Tytherleigh et al, Br J Surg 2008; 95:

Treatment Radical surgery ◦ Total mesorectal excision (TME) ◦ Abdominoperineal resection (APR) Local excision (full thickness) ◦ Transanal endoscopic microsurgery (TEM) ◦ Transanal endoscopic operation (TEO) ◦ Others: Transanal excision

TEM Full thickness excision 1cm resection margin Tumours at 6-15cm from anal verge Sharma et al, Surg Oncol 2003; 12: Karita et al, Gastrointest Endosc 1991; 37:

TEM advantages vs radical surgery Less major postoperative complications (RR 0.16, P<0.0001) Lower perioperative mortality (RR 0.15, P=0.03) Avoids need for stoma (RR 0.11, P< ) Kidane et al, Dis Colon Rectum 2015; 58:

TEM advantages vs radical surgery Lower blood loss (P<0.001) Shorter operative time (103 vs 149mins, P<0.05) Shorter hospital stay (5.7 vs 15.4 days, P<0.0001) Kunitake et al, Perm J 2012; 16: 45-50

TEO Modification of TEM High definition 2D TFT monitor Standard universal laparoscopic instruments

TEO vs TEM Less steep learning curve Relatively shorter surgical time Lower overall costs (€2031 vs €2603, P=0.003) Nieuwenhuis et al, Surg Endosc 2009; 23: Serra-Aracil et al, World J Gastroenterol 2014; 20:

Question How effective is local excision in terms of oncological control?

Local excision vs radical surgery A nationwide cohort study National Cancer Database of American College of Surgeons T1 rectal cancers Higher 5-year local recurrence rate (12.5% vs 6.9%, P<0.003) Lower 5-year disease specific survival rate (93.2% vs 97.2%, P=0.004) You et al, Ann Surg 2007; 245:

TEM vs radical surgery Systemic review and meta-analysis Compared oncological control T1N0M0 rectal adenocarcinoma 1 randomized controlled trial and 12 observational studies 2855 patients Kidane et al, Dis Colon Rectum 2015; 58:

TEM vs radical surgery 5-year local recurrence Kidane et al, Dis Colon Rectum 2015; 58:

TEM vs radical surgery 5-year overall survival Kidane et al, Dis Colon Rectum 2015; 58:

Question How to select the suitable patients for local excision?

Management controversy Local excision does not remove the mesorectum and regional LN Problem of predicting the N (nodal) staging in T1 tumours Tytherleigh et al, Br J Surg 2008; 95:

Lymph node metastasis T1 tumours: 0-12% T2 tumours: 12-28% T3 tumours: 36-79% Chang et al, J Surg Educ 2008; 65(1): 67-72

Preoperative locoregional staging Endorectal ultrasound (ERUS) ◦ T-staging accuracy: 69-97% ◦ N-staging accuracy: 61-80% Klessen et al, Eur Radiol 2007; 17:

Preoperative locoregional staging Magnetic resonance imaging (MRI) ◦ T-staging accuracy: 67-86% ◦ N-staging accuracy: 57-85% Klessen et al, Eur Radiol 2007; 17:

Preoperative locoregional staging Difficult for MRI to differentiate between T1 and T2 tumours. ERUS is more valuable for T-staging Combination of ERUS and MRI is useful for N-staging Mulla et al, Indian J Radiol Imaging 2010; 20: Muthusamy et al, Clin Cancer Res 2007; 13:

Preoperative staging No imaging modality can completely rule out mesorectal nodal involvement Thus pathological examination after local excision is necessary Categorize T1 tumours into low or high risk Iafrate et al, Radiographics 2006; 26:

Haggitt classification Tytherleigh et al, Br J Surg 2008; 95:

Kikuchi classification Kikuchi et al, Dis Colon Rectum 1995; 38: %8-11%12-25% Lymph node metastasis

Histopathological features of T1 tumours Low riskHigh risk DifferentiationWell, moderatePoor Haggitt level1-3- Kikuchi levelSm1, +/- Sm2Sm3, +/- Sm2 Lymphatic or vascular invasion NoYes Resection margin involvement NoYes Tytherleigh et al, Br J Surg 2008; 95:

Low risk vs high risk Long term results from the Memorial Sloan-Kettering Cancer Center Paty et al, Ann Surg 2002; 236: Disease specific survival

Immediate salvage surgery High risk T1 tumours No compromise in outcome when performed immediately after local excision 30-day mortality (P=0.49) Local recurrence (P=0.49) Distant metastasis (P=0.61) Levic et al, Tech Coloproctol 2013; 17:

Local recurrence Salvage surgery Outcomes are inferior to those who initially received radical surgery Only 59% were disease free at a mean follow-up of 39 months after salvage surgery Friel et al, Dis Colon Rectum 2002; 45:

Question Is there a role for adjuvant therapy?

Adjuvant therapy Local excision for T1 and T2 tumours With and without RT Chakravarti et al, Ann Surg 1999; 230: year actuarial local control

Adjuvant therapy Local excision + RT + chemotherapy T1 and T2 cancers 5-year local control rates increased from 81% to 96% Not significant (P=0.15) Chakravarti et al, Ann Surg 1999; 230: 49-54

Adjuvant therapy Systemic review of 11 studies Local excision with chemoRT in T1 and T2 cancers Local recurrence 10% Overall survival 75% Disease specific survival 89% Ung et al, Colorectal Dis 2014; 16:

NCCN guidelines 2015 Early rectal carcinoma High risk pT1, NX T2, NX Low risk pT1, NX ERUS, MRI cT1, N0 (Size <3cm, <30% bowel circumference, mobile) Local excision Salvage surgerySurveillance

Conclusion TEM has a comparable overall survival rate to radical surgery in T1N0M0 rectal cancers Higher local recurrence rate Patient selection is important Imaging and histopathological features help to predict lymph node metastases

Conclusion Full thickness local excision by TEM / TEO is suitable for low risk T1 rectal carcinomas Immediate salvage surgery recommended if high risk features present Adjuvant therapy showed no significant benefit in T1 cancers

Thank you